血管内介入治疗颅内动脉瘤合并缺血性脑血管疾病的临床研究 |
| |
引用本文: | 杨 帆,徐 睿,李佳兵,彭世鑫,仇玉龙,黄志坚,朱 继,张晓冬. 血管内介入治疗颅内动脉瘤合并缺血性脑血管疾病的临床研究[J]. 现代生物医学进展, 2023, 0(9): 1747-1754 |
| |
作者姓名: | 杨 帆 徐 睿 李佳兵 彭世鑫 仇玉龙 黄志坚 朱 继 张晓冬 |
| |
作者单位: | 重庆医科大学附属第一医院神经外科 重庆 400010 |
| |
基金项目: | 国家自然科学基金项目(82102316) |
| |
摘 要: | 摘要 目的:探讨血管内介入治疗颅内动脉瘤(IA)合并缺血性脑血管疾病的安全性和有效性。方法:回顾性分析了2018年1月至2020年12月使用血管内介入治疗IA合并缺血性脑血管疾病的32例临床资料。结果:32例中共发现了35枚IA,37处狭窄。IA平均大小为(5.17±3.12)mm,其中位于颈内动脉有26枚(74%),位于椎基底动脉有9枚(26%),7例(22%)患者术前检查发现存在两枚IA。37处狭窄中,位于椎基底动脉有9处(24%),位于颅外段有8处(22%),其余20处狭窄(54%)均位于颈内动脉,术前平均狭窄率为75.7%。所有病例手术过程顺利,术后IA中达到完全栓塞有31枚(89%),4枚残留颈部(11%)。37处狭窄中,术后平均狭窄率为8.8%,所有患者术后造影脑血管远端均通畅。治疗期间1例支架内再狭窄,1例脑血管痉挛,出院时所有病例改良Rankin评分量表(mRS)均小于2分。32位患者均得到术后全脑血管造影(DSA)随访,随访时间为6到18个月(平均为8.8个月),随访期间1例出现支架内再狭窄。结论:血管内介入治疗IA合并缺血性脑血管疾病是安全有效的,值得临床借鉴应用。
|
关 键 词: | 缺血性脑血管疾病;颅内外血管狭窄;颅内动脉瘤;血管内介入治疗 |
收稿时间: | 2022-10-06 |
修稿时间: | 2022-10-27 |
Clinical Study of Intravascular Intervention for Intracranial Aneurysm Complicated with Ischemic Cerebrovascular Disease |
| |
Abstract: | ABSTRACT Objective: To investigate the safety and effectiveness of endovascular intervention in the treatment of intracranial aneurysm(IA) complicated with ischemic cerebrovascular disease. Methods: The clinical data of 32 patients with IA complicated with ischemic cerebrovascular disease treated by endovascular intervention from January 2018 to December 2020 were retrospectively analyzed. Results: A total of 35 IA and 37 stenoses were found in 32 patients. The average size of IA was (5.17±3.12)mm. Among them,26 aneurysms (74%) were located in the internal carotid artery, 9 aneurysms (26%) were located in the vertebrobasilar artery, and 7 patients (22%) were found to have two intracranial aneurysms before operation. Among 37 stenosis, 9(24%) were located in the vertebrobasilar artery, 8 (22%) were located in the extracranial segment, and the remaining 20 (54%) were located in the internal carotid artery. The average stenosis rate was 75.7% before operation. 31 aneurysms (89%) were completely occluded and 4 aneurysms (11%) remained in the neck. Among 37 stenoses, the average stenosis rate after operation was 8.8%, and the distal cerebral vessels of all patients were unobstructed after operation. During the treatment, there was 1 case of in-stent restenosis and 1 case of cerebral vasospasm. The modified Rankin scale (mRS) was less than 2 in all patients at discharge. All the 32 patients were followed up by digital subtract angiography(DSA) for 6 to 18 months (average 8.8 months). During the follow-up, 1 case had in-stent restenosis. Conclusion: Endovascular intervention is safe and effective in the treatment of IA complicated with ischemic cerebrovascular diseases, which is worthy of clinical reference. |
| |
Keywords: | Ischemic Cerebrovascular Disease Intracranial and Extracranial stenosis Intracranial aneurysm Endovascular interventional treatment |
|
| 点击此处可从《现代生物医学进展》浏览原始摘要信息 |
|
点击此处可从《现代生物医学进展》下载免费的PDF全文 |